ABOUT US
Creative Proteomics provides research services for protein target analysis, biomarker investigation, and multiplex protein profiling across pharmaceutical, biotechnology, academic, and government research settings.
With Luminex-based assay capabilities as a core strength, we support studies involving cytokines and other protein targets in immunology, inflammation, oncology, translational research, and related fields. Our goal is to help researchers generate reliable data through focused platform expertise, quality-managed workflows, and responsive scientific support.
Creative Proteomics is a contract research organization supporting protein target research through specialized analytical services. We work with customers in the pharmaceutical and biotechnology industries, as well as academic institutions and government organizations, to support studies that require reliable protein detection, multiplex analysis, and research-oriented assay solutions.
Our service approach is built around scientific understanding, technical focus, and practical project support. Rather than offering a generic testing model, we aim to provide analytical services that align with real study goals, sample conditions, and target characteristics.
We provide analytical support for protein targets and biomarker-related research, with a particular strength in multiplex protein detection using Luminex technology. Our services are designed to support biological and pharmaceutical R&D teams working across discovery, translational studies, mechanism research, and disease-focused applications.
Luminex is currently the central platform within our protein target analysis services. We emphasize Luminex because it offers a practical and efficient solution for multiplex protein detection, especially in studies where researchers need to evaluate multiple analytes within a single workflow.
This makes Luminex especially valuable for:
By building our current service strength around Luminex, we are able to provide a clearer technical focus and a more credible platform position for researchers seeking dependable multiplex protein analysis.
While Luminex is our primary platform, we also maintain awareness of other relevant analytical approaches and may reference complementary technologies where scientifically appropriate.
These may include flow cytometry, MSD, Simoa, ELISpot, and related protein analysis methods. However, our current core emphasis remains on Luminex-based service delivery.
Our current Luminex-centered platform supports multiplex protein analysis with performance characteristics designed for efficient and research-relevant assay execution.
In a single workflow, with expanded capacity of up to 500 analytes on FLEXMAP 3D.
Sensitivity, depending on assay design and target characteristics.
Supports measurement across a broad concentration window.
Typical sample input per reaction, helping preserve valuable biological materials.
Intra-assay CV <10% and inter-assay CV <15% as current platform precision benchmarks.
Compatible with serum, plasma, CSF, cell supernatant, and lysates.
Our services support a broad range of protein-target-related research applications.
While cytokine analysis is an important part of our work, our broader focus is on helping researchers study protein targets, biomarkers, and multiplex protein signatures across different biological questions and project stages.
We support protein target studies in early-stage research, including target validation, biomarker screening, lead optimization, and protein profiling for mechanism-related studies to support biological decision-making.
Suited for studies involving immune profiling, cytokine/chemokine analysis, infectious disease response, oncology biomarkers, cardiovascular studies, and personalized research strategies.
Focused on inflammation, immune signaling, cytokine dysregulation, cytokine storm, and autoimmune-related pathways requiring multiplex analysis of interconnected targets.
Supporting biomarker investigations across oncology, autoimmune disease, cardiometabolic research, diabetes, and areas where protein targets define disease characterization.
Supporting selected specialized research areas such as neuroscience-related protein studies, veterinary research, and other emerging applications requiring multiplex insight.
Reliable protein analysis depends not only on platform capability, but also on how each assay is controlled, evaluated, and reviewed.
At Creative Proteomics, we place strong emphasis on data quality, assay consistency, and structured quality review to support technically sound and interpretable results.
Our quality-focused workflow includes precision monitoring, matrix-aware performance assessment, quantitative curve evaluation, and structured review of assay behavior before final reporting. Rather than simply generating output, we aim to ensure that the data delivered to clients is suitable for downstream research use and scientific interpretation.
We review assay consistency through intra- and inter-assay performance checks to support reliable quantitative output across runs.
Where required, matrix-related performance is assessed through spike recovery and dilution linearity review to understand assay behavior.
Curve fitting strategies such as 4PL or 5PL models are used as appropriate to support accurate quantitation and better interpretation.
Raw signal behavior, control performance, and overall data patterns are reviewed before reporting to reduce avoidable interpretation risk.
We believe technical transparency is an important part of scientific trust. For protein target and multiplex analysis projects, researchers need more than a final result table — they need confidence in the platform, the workflow, and the reporting logic behind the data. Our current service strength is centered on Luminex-based multiplex analysis, structured to support clear assay execution and practical result delivery.
Luminex-based workflows are selected and structured according to assay complexity, multiplex level, and study requirements.
Signal acquisition, quantitative fitting, and internal data review are organized through a structured workflow to support interpretability.
Project outputs can include structured result tables, processed data summaries, and supporting information aligned with downstream needs.
Successful protein target studies depend on more than assay execution alone. Clear communication, practical planning, and organized project flow are all important for producing useful results and keeping studies on track. We aim to support researchers through a service process that is structured, responsive, and aligned with real project needs.
We begin by understanding study goals, target scope, sample conditions, and overall research priorities.
Project workflows are organized according to platform fit, sample type, multiplex requirements, and reporting expectations.
Experimental work is carried out with attention to assay control, data review, and result consistency.
Results are delivered in formats designed to support downstream interpretation and next-step decision-making.
Researchers choose Creative Proteomics for focused support in protein target analysis, biomarker research, and multiplex protein profiling. Beyond platform capability alone, we aim to provide a clearer technical focus, structured project execution, and practical scientific support.
We position Luminex as the core platform, giving clients a more focused technical pathway for multiplex analysis involving cytokines and other targets.
Aligned with real research contexts (drug discovery, translational, immune analysis) ensuring assay support is grounded in biological relevance.
Strong emphasis on assay consistency, matrix-aware review, curve evaluation, and pre-report data assessment.
Visibility into how data is generated and reviewed, supporting practical project coordination and clearer expectations.
Supporting customers through platform-focused discussion, responsive coordination, and scientific communication from initiation to reporting.
We understand that many protein target and biomarker studies involve unpublished targets, sensitive sample information, proprietary project designs, or early-stage research data. For this reason, confidentiality and controlled project handling are an important part of how we support our clients.
From initial discussion through final data delivery, project communication and data handling are managed through structured internal processes designed to support confidentiality, controlled access, and responsible handling of customer information throughout the service lifecycle.
Projects begin under structured confidentiality expectations to support early-stage technical discussion.
Project files, result outputs, and related communications are managed through controlled internal workflows.
Project visibility is handled on a need-to-know basis within the service workflow to support responsible coordination.
Samples and data can be handled according to agreed expectations for return, retention, or controlled disposition.
In protein target and multiplex biomarker studies, project success often depends on more than assay availability alone. Sample limitations, matrix interference, target abundance, and panel selection uncertainty can all affect data quality and study design. We aim to support researchers by addressing these common challenges through practical workflow planning.
For studies working with small or difficult-to-replace samples, multiplex workflows can help maximize data output from limited input volume.
When target levels are expected to be low, platform selection and assay planning become especially important for meaningful detection.
For challenging matrices such as tissue extracts, workflow adjustments may be needed to reduce interference and improve interpretability.
When projects are still being refined, practical discussion around target grouping and assay fit can help support a suitable panel strategy.
We work with a broad range of research organizations. Our services are designed for teams seeking practical analytical support in protein target research, biomarker exploration, and multiplex protein analysis.
Support for protein target studies, biomarker programs, translational workflows, and disease-focused research applications.
Flexible analytical support for early-stage programs, assay planning, target evaluation, and biomarker-related studies.
Research-oriented services designed to support mechanistic studies, pathway analysis, exploratory biomarker work, and publications.
Structured analytical support for public research programs, translational initiatives, and specialized study needs.
We aim to build long-term collaborations through focused technical capability, responsive communication, and dependable analytical support.
Whether your project involves cytokines, immune-related proteins, disease-associated biomarkers, or broader protein target analysis, Creative Proteomics is ready to support your research goals with Luminex-focused analytical services.
Talk with our team about your assay needs, study design, or project scope.
Online Inquiry
×